Assessment of adherence to highly active antiretroviral therapy in a cohort of African HIV-infected children in Abidjan, Cote d'Ivoire

被引:37
作者
Elise, A
France, AM
Louise, WM
Bata, D
François, R
Roger, S
Philippe, M
机构
[1] Inst Sante Publ Epidemiol & Dev, Equipe VIH Afrique, F-33076 Bordeaux, France
[2] Programme ANRS Cooperat Francaise Cote Ivoire PAC, Projet Enfant, Abidjan, Cote Ivoire
[3] CHU Treichville, Serv Pediat, Abidjan, Cote Ivoire
[4] CHU Treichville, Ctr Diagnost & Rech, SIDA, CeDReS, Abidjan, Cote Ivoire
[5] Inst Rech & Dev IRD, UR 036, Montpellier, France
关键词
adherence; children; highly active antiretroviral therapy; Africa; HIV;
D O I
10.1097/01.qai.0000168180.76405.5f
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
African HIV-infected children benefit from access to antiretroviral treatments but little is known about their adherence. A cross-sectional assessment of adherence to highly active antiretroviral therapy was conducted among a group of children recruited in an observational cohort in Abidjan, Cote d'Ivoire. Adherence was determined by a 1-month recall by child or caregiver, with full adherence signifying no interruptions in the prior month. One-third reported less than full adherence. Undetectable viral load was associated with full adherence in a subset of children with a P value <10% (P = 0.098). As compared with children with full adherence, those with less than full adherence were significantly older and more likely to be taking efavirenz. These findings underscore the necessity of assessing and supporting children's adherence routinely in AIDS care institutions.
引用
收藏
页码:498 / 500
页数:3
相关论文
共 15 条
[1]  
Eley B, 2004, SAMJ S AFR MED J, V94, P643
[2]   Prevalence of elevated cholesterol and associated risk factors among perinatally HIV-infected children (4-19 years old) in pediatric AIDS clinical trials group 219C [J].
Farley, J ;
Gona, P ;
Crain, M ;
Cervia, J ;
Oleske, J ;
Seage, G ;
Lindsey, J .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2005, 38 (04) :480-487
[3]   Assessment of adherence to antiviral therapy in HIV-infected children using the medication event monitoring system, pharmacy refill, provider assessment, caregiver self-report, and appointment keeping [J].
Farley, J ;
Hines, S ;
Musk, A ;
Ferrus, S ;
Tepper, V .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2003, 33 (02) :211-218
[4]   Highly active antiretroviral therapies among HIV-1 infected children in Abidjan, Cote d'Ivoire [J].
Fassinou, P ;
Elenga, N ;
Rouet, F ;
Laguide, R ;
Kouakoussui, KA ;
Timite, M ;
Blanche, S ;
Msellati, P .
AIDS, 2004, 18 (14) :1905-1913
[5]   Measuring adherence to antiretroviral therapy in a diverse population using a visual analogue scale [J].
Giordano, TP ;
Guzman, D ;
Clark, R ;
Charlebois, ED ;
Bangsberg, DR .
HIV CLINICAL TRIALS, 2004, 5 (02) :74-79
[6]  
KALYEBARA J, 2002, 6 INT C DRUG THER HI
[7]   The role of psychosocial and family factors in adherence to antiretroviral treatment in human immunodeficiency virus-infected children [J].
Mellins, CA ;
Brackis-Cott, E ;
Dolezal, C ;
Abrams, EJ .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2004, 23 (11) :1035-1041
[8]   Multiple validated measures of adherence indicate high levels of adherence to generic HIV antiretroviral therapy in a resource-limited setting [J].
Oyugi, JH ;
Byakika-Tusiime, J ;
Charlebois, ED ;
Kityo, C ;
Mugerwa, R ;
Mugyenyi, P ;
Bangsberg, DR .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2004, 36 (05) :1100-1102
[9]   Adherence to protease inhibitor therapy and outcomes in patients with HIV infection [J].
Paterson, DL ;
Swindells, S ;
Mohr, J ;
Brester, M ;
Vergis, EN ;
Squier, C ;
Wagener, MM ;
Singh, N .
ANNALS OF INTERNAL MEDICINE, 2000, 133 (01) :21-30
[10]   Adherence to medication regimens among children with human immunodeficiency virus infection [J].
Reddington, C ;
Cohen, J ;
Baldillo, A ;
Toye, M ;
Smith, D ;
Kneut, C ;
Demaria, A ;
Bertolli, J ;
Hsu, HW .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2000, 19 (12) :1148-1153